Company Fresenius SE & Co. KGaA

Equities

FRE

DE0005785604

Healthcare Facilities & Services

Market Closed - Xetra 11:35:19 2024-06-20 am EDT 5-day change 1st Jan Change
28.35 EUR -0.56% Intraday chart for Fresenius SE & Co. KGaA -5.66% +1.00%

Business Summary

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows:

- hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.;

- perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc.

Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).

Number of employees: 190,863

Sales per Business

EUR in Million2022Weight2023Weight Delta
Fresenius Helios
55.1 %
11,690 28.6 % 12,295 55.1 % +5.18%
Fresenius Kabi
35.7 %
7,779 19.0 % 7,961 35.7 % +2.34%
Fresenius Vamed
9.2 %
2,039 5.0 % 2,043 9.2 % +0.20%

Sales per region

EUR in Million2022Weight2023Weight Delta
Germany
38.6 %
8,766 21.5 % 8,607 38.6 % -1.81%
Spain
20.0 %
-- 4,461 20.0 % -
Europe
13.8 %
9,111 22.3 % 3,081 13.8 % -66.18%
North America
12.3 %
340 0.8 % 2,737 12.3 % +705.00%
Asia Pacific
7.4 %
4,141 10.1 % 1,639 7.4 % -60.42%
Latin America
6.4 %
2,182 5.3 % 1,418 6.4 % -35.01%
Africa
1.6 %
534 1.3 % 356 1.6 % -33.33%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 21-04-11
Director of Finance/CFO 44 18-12-31
Compliance Officer - 23-07-17
Public Communications Contact - -
Investor Relations Contact - 14-12-31
Corporate Officer/Principal - 22-09-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 69 15-05-19
Chairman 69 19-12-31
Director/Board Member 63 16-05-12
Director/Board Member 64 07-07-15
Director/Board Member 74 11-01-27
Director/Board Member 63 22-02-08
Director/Board Member 50 07-12-31
Director/Board Member 61 07-12-31
Director/Board Member 65 18-08-31
Director/Board Member 51 20-04-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 563,237,277 411,394,768 ( 73.04 %) 0 73.04 %

Shareholders

NameEquities%Valuation
Else Kröner-Fresenius-Stiftung
27.00 %
152,074,064 27.00 % 4 834 M €
Harris Associates LP
2.953 %
16,634,431 2.953 % 529 M €
Amundi Asset Management SA (Investment Management)
0.4228 %
2,381,440 0.4228 % 76 M €
Sparinvest SA (Denmark)
0.3359 %
1,891,917 0.3359 % 60 M €
Lemanik Asset Management SA
0.2685 %
1,512,300 0.2685 % 48 M €
AG2R LA MONDIALE GESTION d'ACTIFS SA
0.2488 %
1,401,371 0.2488 % 45 M €
Cobas Asset Management SGIIC SA
0.1716 %
966,342 0.1716 % 31 M €
State Street Global Advisors Ltd.
0.1715 %
965,782 0.1715 % 31 M €
Nordea Investment Management AB (Norway)
0.1627 %
916,332 0.1627 % 29 M €
AllianceBernstein Ltd.
0.1553 %
874,714 0.1553 % 28 M €
NameEquities%Valuation
Yousif Capital Management LLC
0.001671 %
37,651 0.001671 % 299 212 €
GAMMA Investing LLC
0.000015 %
338 0.000015 % 2 686 €
RhumbLine Advisers LP
0.000012 %
271 0.000012 % 2 154 €

Holdings

NameEquities%Valuation
94,380,382 32.17% 4,014,357,236 $

Company contact information

Fresenius SE & Co. KGaA

Else-Kröner-Strasse 1

61352, Bad Homburg

+49 6172 6080

http://www.fresenius.de
address Fresenius SE & Co. KGaA(FRE)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Medical/Nursing Services
Medical/Nursing Services
Medical Specialties
Pharmaceuticals: Major
Pharmaceuticals: Major
Hospital/Nursing Management
Medical/Nursing Services
Pharmaceuticals: Other
  1. Stock Market
  2. Equities
  3. FRE Stock
  4. Company Fresenius SE & Co. KGaA